AXCELIS ANNOUNCES MULTIPLE SHIPMENTS OF PURION IMPLANTERS TO LEADING ANALOG CHIP MANUFACTURER

October 26, 2022 at 8:00 AM EDT

BEVERLY, Mass., Oct. 26, 2022 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced multiple shipments of the Company's PurionH™ high current and PurionXE™ high energy implanters to a leading analog chip manufacturer in North America. These systems are part of a series of multi-year, multi-system purchase orders to support the chipmaker's rapidly expanding device manufacturing capabilities.

President and CEO Mary Puma commented, "We're pleased to support our customer's rapid growth and capacity expansion plans.  These multi-year purchase orders are examples of our customer's confidence in Axcelis to support their goals.  Axcelis' partnership approach has helped us establish longstanding customer relationships."

About Axcelis:

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

Safe Harbor Statement
This press release contains forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for shipments to customers, are based on management's current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

CONTACTS:

Maureen Hart (editorial/media) 978.787.4266
Doug Lawson (investor relations) 978.787.9552

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-multiple-shipments-of-purion-implanters-to-leading-analog-chip-manufacturer-301659535.html

SOURCE Axcelis Technologies, Inc.